A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors.

Wen-Quan WangWu-Hu ZhangHe-Li GaoDan HuangHua-Xiang XuShuo LiTian-Jiao LiShuai-Shuai XuHao LiJiang LongLong-Yun YeChun-Tao WuXuan HanXiao-Hong WangLiang LiuXian-Jun Yu

Published in: Journal of gastroenterology (2021)

We identified a novel risk factor panel, which includes PanNET G3, pancreatic duct dilatation, and perineural invasion; this panel predicted early recurrence of PanNETs after curative resection. Patients with these risk factors can benefit from adjuvant therapy with SSAs.

Keyphrases

risk factors
neuroendocrine tumors
free survival
prognostic factors
cell migration